SecBot SecBot
Home › SEC Filings › Current Report (8-K)

Current Report (8-K)

10,000+ reports analyzed by SecBot AI · browse by date or by stock
TickerTypeSentimentImpactSummaryDate
SHFS8-Kbearish6/10SHF Holdings reported Q2 2026 revenue of $1.93M, up 4.8% YoY, driven by a 50.7% increase in loan program income to $0.8MAug 10, 2026
LTCH8-Kbearish6/10Latch, Inc. (LTCH) reported Q2 2026 results with total revenue of $15.6M, down 18.1% YoY, driven by lower hardware and sAug 10, 2026
CECO8-Kbullish8/10CECO reported a mixed Q2 2026 with GAAP net loss of $(34.8)M due to acquisition costs from the closed Thermon deal, but Aug 10, 2026
MITT8-Kbearish5/10MITT reported Q2 2026 EAD of $0.24 per share, a 10.9% miss versus consensus of $0.27, with the dividend fully covered atAug 10, 2026
TH8-Kbullish7/10Target Hospitality reported Q2 2026 revenue of $85.5M (up 39% YoY) and a net loss of $0.09 per share, beating consensus Aug 10, 2026
VFF8-Kbullish6/10Village Farms reported Q2 2026 results with consolidated net sales of $63.977M, up 7% YoY, and GAAP diluted EPS from conAug 10, 2026
AXSM8-Kneutral6/10Axsome Therapeutics reported Q2 2026 total net product revenue of $218.4M (+46% YoY), driven by AUVELITY ($180.3M, +51% Aug 10, 2026
CEVA8-Kbullish6/10Ceva reported Q2 2026 total revenue of $29.0 million, up 13% YoY, with licensing and related revenue of $18.2 million (uAug 10, 2026
OPAL8-Kbearish7/10OPAL Fuels reported a net loss of $0.05 per share for Q2 2026, a 126% miss versus consensus estimates of $0.19 EPS, despAug 10, 2026
AAON8-Kbullish7/10AAON reported Q2 2026 results with record net sales of $627.0M (up 101.2% YoY) and diluted EPS of $0.68 (up 257.9% YoY),Aug 10, 2026
JBIO8-Kbullish7/10Jade Biosciences reported Q2 2026 results with net loss of -$0.76 per share (vs -$0.86 YoY), a pre-revenue clinical-stagAug 10, 2026
SIF8-Kmixed5/10SIFCO Industries reported mixed Q3 fiscal 2026 results: revenue rose 18.3% YoY to $26.1M, but GAAP net income swung to aAug 10, 2026
MLTX8-Kbullish7/10MoonLake announced positive topline Phase 3 IZAR-1 results for sonelokimab in psoriatic arthritis, meeting all clinical Aug 10, 2026
TNXP8-Kbullish6/10Tonix Pharmaceuticals reported Q2 2026 net product revenue of $13.5M, up 578% YoY from $2.0M, driven by $11.0M in TONMYAAug 10, 2026
APGE8-Kbullish8/10Apogee reported Q2 2026 financial results amid a transformational period: positive Phase 2 APEX Part B data for lead assAug 10, 2026
SLN8-Kneutral5/10Silence Therapeutics reported Q2 2026 net loss of $12.3M ($0.09 per share), narrower than the $27.4M loss in Q2 2025 andAug 10, 2026
CHMI8-K, 425bullish7/10Cherry Hill Mortgage Investment Corporation (CHMI) entered into a definitive merger agreement with TPG Mortgage InvestmeAug 10, 2026
MITT8-Kbullish7/10TPG Mortgage Investment Trust (MITT) entered into a definitive merger agreement to acquire Cherry Hill Mortgage InvestmeAug 10, 2026
RHPS-3ASR, 8-Kbullish7/10Ryman Hospitality Properties (RHP) filed an automatic shelf registration (S-3ASR) on August 10, 2026, to register an indAug 10, 2026
CCXI8-Kneutral3/10Churchill Capital Corp XI (CCXI), a SPAC, has entered into a promissory note with its sponsor for up to $1.5 million forAug 10, 2026
ORKA8-Kneutral5/10The company highlighted key upcoming catalysts including Week 28 data from EVERLAST-A and Week 16 data from EVERLAST-B, Aug 10, 2026
NESR8-Kbullish7/10NESR reported a massive Q2 2026 beat, with revenue of $520.8M (+59% YoY) and adjusted EPS of $0.44 (+169% YoY), both welAug 10, 2026
AIRS8-Kbearish7/10AirSculpt Technologies reported Q2 2026 revenue of $42.9M (-3% YoY), missing consensus of $44.1M, and GAAP EPS of -$0.02Aug 10, 2026
JBGS8-Kbearish7/10JBG SMITH reported Q2 2026 Core FFO of $0.18 per share, down from $0.19 a year ago, with Same Store NOI declining 4.0% YAug 10, 2026
FERG8-Kmixed6/10Ferguson (FERG) reported FQ2 2026 (ended June 30) results with net sales of $8.75B, +4.6% YoY, and diluted GAAP EPS of $Aug 10, 2026
NABL8-Kbearish7/10N-able reported Q2 2026 revenue of $138.2M (+5.9% YoY) and GAAP EPS of $0.01, and significantly lowered its full-year 20Aug 10, 2026
ACH8-Kbearish6/10Accendra Health reported Q2 2026 revenue of $613.2M (down 10.1% YoY from $681.9M) and a GAAP loss from continuing ops ofAug 10, 2026
KEEL8-Kmixed5/10Keel Infrastructure reported Q2 2026 revenue of $30M, down 50% YoY, and a $0.11 GAAP loss per share, swinging from a $0.Aug 10, 2026
CTRN8-Kbullish6/10Citi Trends pre-announced strong preliminary Q2 2026 sales of $211.6M (+10.9% YoY), with comparable store sales growth oAug 10, 2026
ASST8-Kbearish5/10Strive, Inc. reported Q2 2026 financial results showing a GAAP net loss of $257.6M, primarily driven by $234M in unrealiAug 10, 2026
« Previous Page 329 of 334 Next »